ResMed reported $1.57B in Current Assets for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Assets Change
Ansell ANN:AU $ 1.17B 136M
Australian Pharma API:AU $ 989.76M 51.64M
Cochlear COH:AU $ 1.23B 46.5M
CSL CSL:AU $ 7.39B 753.5M
Estia Health EHE:AU $ 51.97M 16.71M
Fisher & Paykel Healthcare FPH:AU 867.7M 52.3M
Healius Ltd HLS:AU $ 330.9M 34.8M
Integral Diagnostics Ltd IDX:AU 82.25M 4.72M
Japara Healthcare JHC:AU 71.08M 11.38M
Mayne Pharma MYX:AU $ 416.53M 49.36M
Nanosonics Ltd NAN:AU $ 142.31M 15.69M
Opthea Ltd OPT:AU 138.12M 74.88M
Polynovo Ltd PNV:AU 16.24M 1.4M
Ramsay Health Care RHC:AU $ 5.35B 1.77B
Regis Healthcare REG:AU 21.94M 43.4M
ResMed RMD:AU $ 1.57B 108.61M
Sigma Healthcare Ltd SIG:AU 734.64M 32.44M
Sonic Healthcare SHL:AU $ 2.28B 98.7M
Telix Pharmaceuticals Ltd TLX:AU 70.3M 23.32M